Neurocrine Bio. (NBIX) PT Raised to $87 at SVB Leerink
Tweet
Share
E-mail
Get Alerts NBIX Hot Sheet
Price: $156.22 -0.22%
Rating Summary:
30 Buy, 6 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 3 | Down: 5 | New: 34
Rating Summary:
30 Buy, 6 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 3 | Down: 5 | New: 34
Join SI Premium – FREE
SVB Leerink analyst Marc Goodman raised the price target on Neurocrine Bio. (NASDAQ: NBIX) to $87.00 (from $84.00) while maintaining a Market Perform rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Neurocrine Bio. (NBIX) PT Raised to $183 at Morgan Stanley
- Inspire Medical Systems (INSP) PT Raised to $80 at Stifel
- Adobe (ADBE) PT Raised to $255 at UBS Following Q3 Results
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
